- Home
- TREE vs BBNX Comparison
TREE vs BBNX Comparison
Compare TREE & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- BBNX
- Stock Information
- Founded
- TREE 1996
- BBNX 2015
- Country
- TREE United States
- BBNX United States
- Employees
- TREE N/A
- BBNX N/A
- Industry
- TREE Finance: Consumer Services
- BBNX Medical/Dental Instruments
- Sector
- TREE Finance
- BBNX Health Care
- Exchange
- TREE Nasdaq
- BBNX Nasdaq
- Market Cap
- TREE 978.1M
- BBNX 967.6M
- IPO Year
- TREE N/A
- BBNX 2025
- Fundamental
- Price
- TREE $60.68
- BBNX $28.61
- Analyst Decision
- TREE Buy
- BBNX Strong Buy
- Analyst Count
- TREE 8
- BBNX 11
- Target Price
- TREE $65.38
- BBNX $26.09
- AVG Volume (30 Days)
- TREE 220.6K
- BBNX 574.5K
- Earning Date
- TREE 10-30-2025
- BBNX 10-28-2025
- Dividend Yield
- TREE N/A
- BBNX N/A
- EPS Growth
- TREE N/A
- BBNX N/A
- EPS
- TREE N/A
- BBNX N/A
- Revenue
- TREE $1,012,155,000.00
- BBNX $78,022,000.00
- Revenue This Year
- TREE $17.19
- BBNX $43.04
- Revenue Next Year
- TREE $7.58
- BBNX $35.60
- P/E Ratio
- TREE N/A
- BBNX N/A
- Revenue Growth
- TREE 51.65
- BBNX 550.45
- 52 Week Low
- TREE $33.50
- BBNX $8.89
- 52 Week High
- TREE $77.35
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- TREE 48.27
- BBNX 75.20
- Support Level
- TREE $55.94
- BBNX $19.52
- Resistance Level
- TREE $63.67
- BBNX $22.54
- Average True Range (ATR)
- TREE 2.75
- BBNX 1.56
- MACD
- TREE 0.56
- BBNX 0.60
- Stochastic Oscillator
- TREE 79.04
- BBNX 100.00
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.